Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.95 USD | +0.02% | +0.54% | +240.77% |
May. 10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
May. 09 | Alpine Immune Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 23.6M | Sales 2025 * | 20.2M | Capitalization | 4.45B |
---|---|---|---|---|---|
Net income 2024 * | -99M | Net income 2025 * | -110M | EV / Sales 2024 * | 179 x |
Net cash position 2024 * | 233M | Net cash position 2025 * | 208M | EV / Sales 2025 * | 210 x |
P/E ratio 2024 * |
-53.4
x | P/E ratio 2025 * |
-36.8
x | Employees | 142 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.13% |
Latest transcript on Alpine Immune Sciences, Inc.
1 day | +0.02% | ||
1 week | +0.54% | ||
Current month | +0.56% | ||
1 month | +0.82% | ||
3 months | +125.76% | ||
6 months | +461.85% | ||
Current year | +240.77% |
Managers | Title | Age | Since |
---|---|---|---|
Mitchell Gold
CEO | Chief Executive Officer | 57 | 17-07-23 |
Director of Finance/CFO | - | 17-05-31 | |
Stanford Peng
PSD | President | 53 | 17-07-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Conway
BRD | Director/Board Member | 70 | 17-06-30 |
Mitchell Gold
CEO | Chief Executive Officer | 57 | 17-07-23 |
James Topper
BRD | Director/Board Member | 62 | 16-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.64% | 4 M€ | -5.15% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +9.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 64.95 | +0.02% | 2,962,719 |
24-05-10 | 64.94 | +0.19% | 3,047,933 |
24-05-09 | 64.82 | +0.19% | 1,141,451 |
24-05-08 | 64.7 | +0.09% | 748,953 |
24-05-07 | 64.64 | +0.06% | 1,332,282 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+240.77% | 4.45B | |
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+3.33% | 13.76B | |
+36.58% | 12.46B |
- Stock Market
- Equities
- ALPN Stock